Results 201 to 210 of about 105,303 (279)
Graft–Vs.–Host Disease After Liver Transplantation [PDF]
Graeme Alexander, B Portmann
openalex +1 more source
This review traces the evolution of functional biliary stents, outlining the paradigm shift from “active intervention” strategies that target stent failure to next‐generation “enabling platforms.” These platforms leverage biodegradable materials, 3D/4D printing, and smart sensors to achieve personalized, regenerative, and theranostic solutions ...
Muhan Li +4 more
wiley +1 more source
Erosive Tarsal Conjunctival Lesions Following Immunogenic Events in Early Development of Ocular Graft-vs-Host Disease. [PDF]
Kohnstam MG, Surico PL, Luo ZK.
europepmc +1 more source
Management of Chronic Graft-vs.-Host Disease in Children and Adolescents With ALL: Present Status and Model for a Personalised Management Plan. [PDF]
Sobkowiak-Sobierajska A +7 more
europepmc +1 more source
Schematic representation of nanoparticle‐integrated electrostimulation‐responsive biomaterials for controlled drug delivery and tissue regeneration. Electroactive scaffolds including conductive polymers, electroresponsive hydrogels, and piezoelectric matrices are shown incorporating therapeutic nanoparticles (such as iron oxide, silver, and carbon ...
Peyman Halvaeikhanekahdani +3 more
wiley +1 more source
Reduced prevalence of periodontitis in antidepressant users: Findings from a large‐scale US sample
Abstract Background Periodontitis and major depression disorder have been shown to have a bidirectional association. However, the impact of antidepressants, the primary pharmacological treatment for depression, on periodontal health remains unclear.
María Martínez +3 more
wiley +1 more source
Correction to: "Severe Hypertriglyceridemia in a Patient Treated With Sirolimus for Graft-vs-Host Disease Prophylaxis". [PDF]
europepmc +1 more source
Specificity of T cells invading the skin during acute graft-vs.-host disease after semiallogeneic bone marrow transplantation. [PDF]
Joëlle Gaschet +9 more
openalex +1 more source

